삼성서울병원

Ko En

Ahn, Yong Chan M.D

TITLE
Professor
Department of Radiation Oncology
Samsung Medical Center
Sungkyunkwan University School of Medicine
Treament Schedule 08 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
MON
31
AM
PM
Treament Schedule 09 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   1992. 08 ~ 1993. 06: Research Fellow, Roswell Park Cancer Institute, USA
1993. 07 ~ 1994. 04: Clinical Fellow, British Columbia Cancer Agency, Canada
Residency   1989. 05 ~ 1992. 02: Seoul National University Hospital
Internship   1984. 03 ~ 1985. 02: Seoul National University Hospital

Other Education

2003. 08 ~ 2003. 10: Visiting Professor, Hokkaido University Medical School

Clinical & Research Interests

Head/Neck Oncology
Thoracic Oncology (Lung cancer, Esophageal cancer, Mediastinal tumor)
Stomach Cancer
Lymphoma
Sarcoma

Participation in Academic Societies
and Research

Domestic:
2001. 01 ~ Director, The Korean Lung Cancer Study Group
2004. 07 ~ Director, Korean Cancer Association
2004. 10 ~ 2007. 09: Director of General Affairs and Treasury, Korean Society for Therapeutic Radiology and Oncology
2007. 10 ~ Director of Board Qualifying Examination, Korean Society for Therapeutic Radiology and Oncology
2008. 10 ~ Vice-Editor-in-Chief, Korean Cancer Association
2008. 11 ~ Director of Public Relation, Korean Society for Head & Neck Oncology

International Membership:
American Society for Therapeutic Radiology and Oncology (ASTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)

Selected Publications

  • Journal of thoracic disease 2020 10.21037/jtd.2020.03.23 Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery Shin1, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM
    View PubMed
  • CANCERS 2020 10.3390/cancers12040925 Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer Yoon1, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2019.10.022 Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC Tan1, WL; Chua, KLM; Lin, CC; Lee, VHF; Tho, LM; Chan, AW; Ho, GF; Reungwetwattana, T; Yang, JC; Kim, DW; Soo, RA; Ahn, YC; Onishi, H; Ahn, MJ; Mok, TSK; Tan, DSW; Yang, F
    View PubMed
  • ANN ONCOL 2020 10.1016/j.annonc.2019.10.026 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS Park1, K; Vansteenkiste, J; Lee, KH; Pentheroudakis, G; Zhou, C; Prabhash, K; Seto, T; Voon, PJ; Tan, DSW; Yang, JCH; Wang, J; Babu, KG; Nakayama, Y; Alip, A; Chua, KLM; Cheng, JCH; Senan, S; Ahn, YC; Kim, TY; Ahn, HK; Peters, S; Yoshino, T; Douillard, JY
    View PubMed
  • HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH
    View PubMed